4.4 Article

The impact of common genetic variants in cognitive decline in the first seven years of Parkinson's disease: A longitudinal observational study

Related references

Note: Only part of the references are listed.
Article Neurosciences

Dopaminergic degeneration induces early posterior cortical thinning in Parkinson's disease

Frederic Sampedro et al.

NEUROBIOLOGY OF DISEASE (2019)

Article Clinical Neurology

APOE, Thought Disorder, and SPARE-AD Predict Cognitive Decline in Established Parkinson's Disease

Thomas F. Tropea et al.

MOVEMENT DISORDERS (2018)

Article Clinical Neurology

Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease

Johannes J. Gaare et al.

MOVEMENT DISORDERS (2018)

Article Clinical Neurology

Polymorphisms in dopamine-associated genes and cognitive decline in Parkinson's disease

D. Backstrom et al.

ACTA NEUROLOGICA SCANDINAVICA (2018)

Review Clinical Neurology

Cognitive decline in Parkinson disease

Dag Aarsland et al.

NATURE REVIEWS NEUROLOGY (2017)

Article Geriatrics & Gerontology

Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's disease

Ignacio F. Mata et al.

NEUROBIOLOGY OF AGING (2017)

Article Clinical Neurology

GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease

Ignacio F. Mata et al.

MOVEMENT DISORDERS (2016)

Article Neurosciences

APOE, MAPT, and COMT and Parkinson's Disease Susceptibility and Cognitive Symptom Progression

Kimberly C. Paul et al.

JOURNAL OF PARKINSONS DISEASE (2016)

Article Geriatrics & Gerontology

BDNF polymorphism associates with decline in set shifting in Parkinson's disease

Nicolien M. van der Kolk et al.

NEUROBIOLOGY OF AGING (2015)

Article Clinical Neurology

Predictors of dementia in Parkinson's disease; findings from a 5-year prospective study using the SCOPA-COG

Kangdi Zhu et al.

PARKINSONISM & RELATED DISORDERS (2014)

Article Clinical Neurology

APOE, MAPT, and SNCA Genes and Cognitive Performance in Parkinson Disease

Ignacio F. Mata et al.

JAMA NEUROLOGY (2014)

Article Clinical Neurology

Cognitive Impairment in Parkinson's Disease: The Dual Syndrome Hypothesis

Angie A. Kehagia et al.

NEURODEGENERATIVE DISEASES (2013)

Article Geriatrics & Gerontology

Cognitive Impairment in Parkinson Disease: Impact on Quality of Life, Disability, and Caregiver Burden

Iracema Leroi et al.

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2012)

Article Clinical Neurology

Genetic influences on cognitive decline in Parkinson's disease

James F. Morley et al.

MOVEMENT DISORDERS (2012)

Article Clinical Neurology

Catechol-O-methyltransferase Val158Met and Cognitive Function in Parkinson's Disease

Jeroen Hoogland et al.

MOVEMENT DISORDERS (2010)

Article Clinical Neurology

Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's Disease

Caroline H. Williams-Gray et al.

JOURNAL OF NEUROLOGY (2009)

Article Clinical Neurology

Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study

G. Alves et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)

Review Clinical Neurology

Clinical diagnostic criteria for dementia associated with Parkinson's disease

Murat Emre et al.

MOVEMENT DISORDERS (2007)

Article Genetics & Heredity

PLINK: A tool set for whole-genome association and population-based linkage analyses

Shaun Purcell et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2007)

Article Clinical Neurology

Tau and α-synuclein in susceptibility to, and dementia in, Parkinson's disease

An Goris et al.

ANNALS OF NEUROLOGY (2007)

Article Clinical Neurology

Prognosis of Parkinson disease - Risk of dementia and mortality: The Rotterdam Study

LML de Lau et al.

ARCHIVES OF NEUROLOGY (2005)